U.S. market Closed. Opens in 1 day 5 hours 29 minutes

XENE | Xenon Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
RevenueN/A9.43M18.44M32.17M6.83MN/A311.00K1.80M15.58M28.37M27.36M14.31M6.92M
Cost of Revenue167.51M105.77M75.46M50.52M38.84M6.00M25.57M1.11M2.76M5.90M6.21M7.32MN/A
Gross Profit-167.51M-96.33M-57.03M-18.36M-32.02M-6.00M-25.26M689.00K12.81M22.47M21.15M6.99M6.92M
Operating Expenses46.54M138.58M97.43M63.47M49.65M32.02M32.89M26.62M24.94M17.26M17.64M17.46M19.03M
Selling, General & Admin46.54M32.81M21.97M12.94M10.80M8.38M7.31M6.79M9.79M5.50M5.34M7.01M6.73M
Research & Development167.51M105.77M75.46M50.52M38.84M23.63M25.57M19.83M15.15M11.77M12.30M10.46M12.30M
Other Operating Expenses-167.51M3.89M105.00K2.21MN/A4.40MN/AN/A-6.39MN/AN/AN/AN/A
Operating Income-214.05M-129.14M-78.99M-31.30M-42.82M-38.02M-32.58M-24.82M-9.36M11.11M9.71M-3.15M-12.11M
Other Expenses / Income31.37M3.89M105.00K2.21M1.20M6.40M1.87M1.82M-6.39M1.91M2.32M-1.15M122.00K
Before Tax Income-182.69M-125.25M-78.89M-29.09M-41.62M-34.50M-30.70M-23.00M-15.75M13.02M12.03M-4.30M-11.99M
Income Tax Expenses292.00K118.00K-6.00K-257.00K-23.00K4.91M-1.87M-1.82M-1.04MN/A64.00K93.00K91.00K
Net Income-182.39M-125.37M-78.88M-28.84M-41.59M-34.50M-30.70M-23.00M-15.75M13.02M12.03M-4.30M-11.99M
Interest ExpensesN/AN/AN/A484.00K1.43M1.39MN/AN/AN/AN/A64.00K93.00K91.00K
Basic Shares Outstanding66.89M60.54M43.63M34.54M25.94M19.43M17.99M15.49M14.28M3.17M9.09M9.09M9.08M
Diluted Shares Outstanding66.89M60.54M43.63M34.54M25.94M19.43M18.00M15.49M14.28M3.96M9.83M9.83M9.74M
EBITDA-210.51M-127.52M-78.09M-27.97M-39.76M-32.54M-30.05M-23.95M-8.32M11.84M10.42M-3.42M-10.77M
EBITDA Margin0.00%-1,351.70%-423.53%-86.94%-582.15%0.00%-9,663.99%-1,328.51%-53.43%41.75%38.08%-23.92%-155.67%
EBIT-182.10M-125.25M-78.89M-28.61M-40.18M-28.19M-32.58M-24.82M-16.79M13.02M12.16M-4.12M-11.81M
EBIT Margin0.00%-1,327.70%-427.88%-88.94%-588.43%0.00%-10,474.28%-1,376.43%-107.79%45.89%44.45%-28.76%-170.71%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙